Template:Ganglioglioma: Difference between revisions
Jump to navigation
Jump to search
Varun Kumar (talk | contribs) No edit summary |
No edit summary |
||
(4 intermediate revisions by 2 users not shown) | |||
Line 16: | Line 16: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Ganglioglioma (patient information)|Patient | [[Ganglioglioma (patient information)|Patient Information]] | ||
|- | |- | ||
! | ! | ||
Line 29: | Line 29: | ||
! | ! | ||
[[Ganglioglioma historical perspective|Historical Perspective]] | [[Ganglioglioma historical perspective|Historical Perspective]] | ||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Ganglioglioma classification|Classification]] | |||
|- | |- | ||
! | ! | ||
Line 40: | Line 46: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Ganglioglioma | [[Ganglioglioma causes|Causes]] | ||
|- | |- | ||
! | ! | ||
Line 46: | Line 52: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Ganglioglioma | [[Ganglioglioma epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
Line 52: | Line 58: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Ganglioglioma | [[Ganglioglioma risk factors|Risk Factors]] | ||
|- | |- | ||
! | ! | ||
Line 58: | Line 64: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Ganglioglioma | [[Ganglioglioma screening|Screening]] | ||
|- | |- | ||
! | ! | ||
Line 70: | Line 76: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Ganglioglioma natural history|Natural History, Complications | [[Ganglioglioma natural history|Natural History, Complications and Prognosis]] | ||
|- | |- | ||
! | ! | ||
Line 82: | Line 88: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Ganglioglioma | [[Ganglioglioma staging|Staging]] | ||
|- | |- | ||
! | ! | ||
Line 88: | Line 94: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Ganglioglioma | [[Ganglioglioma history and symptoms|History and Symptoms]] | ||
|- | |- | ||
! | ! | ||
Line 94: | Line 100: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Ganglioglioma | [[Ganglioglioma physical examination|Physical Examination]] | ||
|- | |- | ||
! | ! | ||
Line 100: | Line 106: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Ganglioglioma | [[Ganglioglioma laboratory tests|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
Line 106: | Line 112: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Ganglioglioma | [[Ganglioglioma X Ray|X Ray]] | ||
|- | |- | ||
! | ! | ||
Line 124: | Line 130: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Ganglioglioma | [[Ganglioglioma ultrasound|Ultrasound]] | ||
|- | |- | ||
! | ! | ||
Line 160: | Line 166: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Ganglioglioma | [[Ganglioglioma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | ||
|- | |- | ||
! | ! | ||
Line 166: | Line 172: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Ganglioglioma | [[Ganglioglioma future or investigational therapies|Future or Investigational Therapies]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="CadetBlue" | ||
! | ! | ||
Case Studies | |||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Ganglioglioma | [[Ganglioglioma case study one|Case #1]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleGoldenrod " | |- bgcolor="PaleGoldenrod " |
Latest revision as of 13:33, 7 September 2015
Ganglioglioma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ganglioglioma On the Web |
American Roentgen Ray Society Images of Ganglioglioma |